Position
Creative Planning in Immunovant, Inc.
Back to the book · All holders of IMVT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$24.1K$25.42 → $24.84
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 41.5K | $1.05M | — | — | — | 0.0% |
| Q1 2026 | 45.7K | $1.14M | $24.84 | −$24.1K | $105K | 0.0% |